Vimarsana
Biggest News Aggregation in the World

Page 3 - Fed Cir News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fed Cir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fed Cir Today - Breaking & Trending Today

Label ruling upends generic medicine makers - Vimarsana News

Label ruling upends generic medicine makers

The effects of the ‘skinny label’ decision are still being felt across pharma. MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch revisits GSK v Teva.

What Preclusion? Post-IPR Reexam Moves Forward - Vimarsana News

What Preclusion? Post-IPR Reexam Moves Forward

The US Court of Appeals for the Federal Circuit revived a Petitioner’s validity challenge seeking ex parte review at the US Patent & Trademark Office…

What Preclusion? Post-IPR Reexam Moves Forward | McDermott Will & Emery - Vimarsana News

What Preclusion? Post-IPR Reexam Moves Forward | McDermott Will & Emery

The US Court of Appeals for the Federal Circuit revived a petitioner’s validity challenge seeking ex parte review at the US Patent & Trademark Office (PTO), reversing a district court...

IAM - Global Patent Litigation 2022 - Vimarsana News

IAM - Global Patent Litigation 2022

IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.

Patent applications: Kite raises the game - Vimarsana News

Patent applications: Kite raises the game

A duo of cases from the Federal Circuit has added complexities to the drafting of patent applications for antibody inventions, explain Hailey Bureau of BSKB and Olayinka Oladele of the Thurgood Marshall School of Law.